Pharma slows Feb's key exports growth to 4.2%, but analysts not worried
CHINESE New Year festivities and a plunge in pharmaceutical exports are the two reasons identified for Singapore's underwhelming performance in key exports in February. On the other hand, gold and technology glittered. Though the figures came in below expectations, analysts remain confident in growth prospects for the year.
Non-oil domestic exports (NODX) grew by a slower 4.2 per cent year-on-year last month, compared to January's flying start of 12.7 per cent, according to data from trade agency Enterprise Singapore on Wednesday. This is lower than the 6.1 per cent forecast by analysts in a Bloomberg poll.
"The moderation in momentum was not entirely unexpected given the change in Chinese New Year timings, which fell in January last year but February in 2021," said Selena Ling, OCBC Bank's head of treasury research and strategy.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Economy & Policy
Singapore factory output reverses into negative territory in March, down 9.2%
Tripartism and trust will help Singapore navigate a world ‘fraught with uncertainties’: Tan See Leng
Daily Debrief: What Happened Today (Apr 26)
Singapore must prepare for slower growth at higher costs: MAS
Outgoing Singapore, Indonesia leaders to hold their final retreat in Bogor on Apr 29
Singapore’s growth should strengthen to ‘around potential rate’, output gap to close by end-2024: MAS